Guardian Pharmacy ServicesGRDN -0.24%42 EBITDA Margin % is 7.26% as of Mar. 2026, which is 11% above its 10-year median of 6.52. GuruFocus rates GRDN with a GF Score™ of 42/100. The stock has 4 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Guardian Pharmacy Services ranks worse than 59.34% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Guardian Pharmacy Services EBITDA Margin % Related Terms
Guardian Pharmacy Services EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GRDN vs ACHC, ASTH, NHC: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Guardian Pharmacy Services's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guardian Pharmacy Services EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Guardian Pharmacy Services's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Guardian Pharmacy Services's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guardian Pharmacy Services (GRDN) has a EBITDA Margin % of 7.26% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Guardian Pharmacy Services and its competitors. This is 11% above median its historical median of 6.52. According to the industry distribution chart, Guardian Pharmacy Services ranks #394 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 59.3%.
Is Guardian Pharmacy Services' EBITDA Margin % too high?
Guardian Pharmacy Services' current EBITDA Margin % of 7.26% is 11% above median its 10-year median of 6.52. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Guardian Pharmacy Services' value of 7.26% is 29.1% below this industry median. Based on the distribution chart, Guardian Pharmacy Services ranks #394 out of 664 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Guardian Pharmacy Services has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Guardian Pharmacy Services' EBITDA Margin % compare to ACHC and ASTH?
According to the Healthcare Providers & Services industry distribution chart, Guardian Pharmacy Services ranks #394 out of 664 companies for EBITDA Margin %. This places Guardian Pharmacy Services in the lower half of its industry. The industry median EBITDA Margin % is 10.24. Guardian Pharmacy Services' value of 7.26% is 29.1% below this benchmark. While the company's 10-year median is 6.52 vs. the industry median of 10.24, Guardian Pharmacy Services has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guardian Pharmacy Services's current EBITDA Margin % of 7.26% is 29.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Guardian Pharmacy Services and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guardian Pharmacy Services's current EBITDA Margin % is 7.26%, which is 11% above median its own 10-year median of 6.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guardian Pharmacy Services stock overvalued right now?
Guardian Pharmacy Services (GRDN) has a current EBITDA Margin % of 7.26%. The current EBITDA Margin % is 7.26%, which is 11% above median its 10-year median of 6.52 and 29.1% below the Healthcare Providers & Services industry median of 10.24. Guardian Pharmacy Services' overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Guardian Pharmacy Services (GRDN), the current EBITDA Margin % is 7.26% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.
42GF Score
Get the complete analysis for GRDN
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRDN has been successfully added to your 
